Towards Precision Medicine: Inclusion of Sex and Gender Aspects in COVID-19 Clinical Studies-Acting Now before It Is Too Late-A Joint Call for Action

Int J Environ Res Public Health. 2020 May 25;17(10):3715. doi: 10.3390/ijerph17103715.

Evelyne Bischof^{1

2

3}, Sabine Oertelt-Prigione^{4

5}, Rosemary Morgan⁶, Sabra L Klein^{7

8}, The Sex And Gender In Covid Clinical Trials Working Group Sgc, Gender And Covid Working Group

¹ Department of Advanced Biomedical Sciences, Federico II University of Naples, Via Pansini, 5, 80131 Naples, Italy.
² School of Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
³ Women's Brain Project, 8357 Guntershausen, Switzerland.
⁴ Department of Primary and Community Care, Radboud University Medical Center, 6525 Nijmegen, The Netherlands.
⁵ Institute of Legal and Forensic Medicine, Charité-Universitätsmedizin, 10117 Berlin, Germany.
⁶ Department of International Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
⁷ W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
⁸ Department of Biochemistry and Molecular Biology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Abstract

The COVID-19 global pandemic is accelerating investigations for effective vaccines and repurposable validated therapeutics [...].